Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $952.52 | 55 | 88.4% |
| Education | $125.14 | 3 | 11.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $218.51 | 10 | $0 (2020) |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $122.20 | 1 | $0 (2017) |
| OPKO Pharmaceuticals, LLC | $78.91 | 6 | $0 (2020) |
| Travere Therapeutics, Inc. | $56.79 | 4 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $56.14 | 4 | $0 (2020) |
| Keryx Biopharmaceuticals, Inc. | $54.70 | 3 | $0 (2018) |
| GENZYME CORPORATION | $52.58 | 4 | $0 (2019) |
| Mallinckrodt Enterprises LLC | $37.77 | 2 | $0 (2019) |
| Astellas Pharma US Inc | $34.26 | 2 | $0 (2020) |
| Melinta Therapeutics, Inc. | $34.18 | 2 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28.50 | 2 | Travere Therapeutics, Inc. ($28.50) |
| 2020 | $159.91 | 10 | Otsuka America Pharmaceutical, Inc. ($31.67) |
| 2019 | $420.88 | 22 | Otsuka America Pharmaceutical, Inc. ($150.27) |
| 2018 | $204.82 | 13 | Keryx Biopharmaceuticals, Inc. ($38.57) |
| 2017 | $263.55 | 11 | Otsuka Pharmaceutical Development & Commercialization, Inc. ($122.20) |
All Payment Transactions
58 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/04/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $23.41 | General |
| 06/04/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $5.09 | General |
| 03/11/2020 | TETRAPHASE PHARMACEUTICALS, INC. | XERAVA (Drug) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: TETRACYCLINE CLASS ANTIBACTERIAL | ||||||
| 03/03/2020 | Travere Therapeutics, Inc. | (815) Thiola (Drug) | Food and Beverage | In-kind items and services | $11.75 | General |
| Category: Kidney Stones | ||||||
| 02/27/2020 | Astellas Pharma US Inc | CRESEMBA (Drug), AMBISOME, MYCAMINE | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: HOSPITAL AND TRANSPLANT | ||||||
| 02/14/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $14.62 | General |
| Category: NEPHROLOGY | ||||||
| 02/13/2020 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/15/2020 | Amgen Inc. | Parsabiv (Drug) | Food and Beverage | In-kind items and services | $17.79 | General |
| Category: Nephrology | ||||||
| 01/15/2020 | OPKO Pharmaceuticals, LLC | RAYALDEE (Drug) | Food and Beverage | In-kind items and services | $11.62 | General |
| Category: Hyperparathyroidism | ||||||
| 01/10/2020 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: NEPHROLOGY | ||||||
| 01/09/2020 | Travere Therapeutics, Inc. | (815) Thiola (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Kidney Stones | ||||||
| 01/07/2020 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: ANTIBIOTIC | ||||||
| 12/13/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Education | In-kind items and services | $61.20 | General |
| Category: NEPHROLOGY | ||||||
| 12/13/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Education | In-kind items and services | $61.20 | General |
| Category: NEPHROLOGY | ||||||
| 12/03/2019 | Mayne Pharma Inc. | DORYX (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: DERMATOLOGY | ||||||
| 11/26/2019 | Astellas Pharma US Inc | CRESEMBA (Drug), MYCAMINE, AMBISOME | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/22/2019 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Drug) | Food and Beverage | In-kind items and services | $20.76 | General |
| Category: Immunology | ||||||
| 11/13/2019 | Lundbeck LLC | NORTHERA (Drug) | Food and Beverage | Cash or cash equivalent | $18.31 | General |
| Category: NEUROLOGY | ||||||
| 09/19/2019 | Mayne Pharma Inc. | DORYX (Drug) | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: DERMATOLOGY | ||||||
| 09/04/2019 | Shire North American Group Inc | NATPARA (PARATHYROID HORMONE) (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: INTERNAL MEDICINE | ||||||
| 08/21/2019 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/15/2019 | Retrophin, Inc. | (815) Thiola (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Kidney Stones | ||||||
| 07/18/2019 | AKEBIA THERAPEUTICS INC | AURYXIA (Drug) | Food and Beverage | Cash or cash equivalent | $20.50 | General |
| Category: NEPHROLOGY | ||||||
| 06/06/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $11.15 | General |
| Category: Hyperparathyroidism | ||||||
| 05/01/2019 | OPKO Pharmaceuticals, LLC | Rayaldee (Drug) | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Hyperparathyroidism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 189 | 315 | $90,374 | $19,731 |
| 2022 | 11 | 300 | 594 | $224,493 | $67,866 |
| 2021 | 13 | 412 | 1,170 | $314,140 | $97,659 |
| 2020 | 12 | 422 | 1,484 | $241,524 | $78,615 |
All Medicare Procedures & Services
42 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 68 | 166 | $41,542 | $9,689 | 23.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 42 | 43 | $20,225 | $4,091 | 20.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 25 | 35 | $12,250 | $2,297 | 18.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 30 | $7,500 | $1,637 | 21.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2023 | 18 | 29 | $7,303 | $1,569 | 21.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 12 | $1,554 | $449.76 | 28.9% |
| 90960 | Dialysis services, 4 or more physician visits per month (20 years or older) | Office | 2022 | 20 | 91 | $63,245 | $25,391 | 40.1% |
| 90961 | Dialysis services, 2-3 physician visits per month (20 years or older) | Office | 2022 | 17 | 42 | $24,486 | $9,843 | 40.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 43 | 102 | $35,470 | $7,971 | 22.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 65 | 140 | $33,866 | $7,541 | 22.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 26 | 27 | $18,249 | $3,972 | 21.8% |
| 90935 | Hemodialysis procedure with physician evaluation | Facility | 2022 | 33 | 67 | $16,595 | $3,783 | 22.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 20 | 25 | $8,750 | $2,971 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 32 | $8,000 | $2,751 | 34.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 20 | 20 | $9,062 | $1,849 | 20.4% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 20 | 35 | $4,495 | $996.04 | 22.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 13 | $2,275 | $798.43 | 35.1% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 25 | 109 | $74,180 | $30,580 | 41.2% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 100 | 237 | $82,355 | $19,052 | 23.1% |
| 90961 | Dialysis services (2-3 physician visits per month), patient 20 years of age and older | Office | 2021 | 21 | 52 | $29,425 | $11,998 | 40.8% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 45 | 45 | $30,397 | $7,009 | 23.1% |
| 90962 | Dialysis services (1 physician visit per month), patient 20 years of age and older | Office | 2021 | 15 | 42 | $18,552 | $6,778 | 36.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 68 | 90 | $21,990 | $5,031 | 22.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 45 | 52 | $13,000 | $4,679 | 36.0% |
| 90970 | Dialysis services, per day (less than full month service), patient 20 years of age or older | Office | 2021 | 14 | 449 | $11,674 | $3,431 | 29.4% |
About Dr. Oliver Phan, MD
Dr. Oliver Phan, MD is a Nephrology healthcare provider based in Edina, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/07/2008. The National Provider Identifier (NPI) number assigned to this provider is 1942463229.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Oliver Phan, MD has received a total of $1,078 in payments from pharmaceutical and medical device companies, with $28.50 received in 2024. These payments were reported across 58 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($952.52).
As a Medicare-enrolled provider, Phan has provided services to 1,323 Medicare beneficiaries, totaling 3,563 services with total Medicare billing of $263,871. Data is available for 4 years (2020–2023), covering 42 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Location Edina, MN
- Active Since 07/07/2008
- Last Updated 01/20/2016
- Taxonomy Code 207RN0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1942463229
Products in Payments
- SAMSCA (Drug) $158.97
- TOLVAPTAN (Drug) $122.20
- Rayaldee (Drug) $67.29
- JYNARQUE (Drug) $59.54
- LOKELMA (Drug) $56.14
- Auryxia (Drug) $54.70
- (815) Thiola (Drug) $43.40
- FABRY-DISEASE (Drug) $39.35
- ACTHAR (Biological) $37.77
- CRESEMBA (Drug) $34.26
- Baxdela (Drug) $34.18
- DORYX (Drug) $32.10
- XERAVA (Drug) $25.00
- Rituxan (Biological) $24.34
- Renal - PD (Device) $24.17
- OCTAPLAS (Biological) $21.51
- ULTOMIRIS (Drug) $20.76
- AURYXIA (Drug) $20.50
- NUZYRA (Drug) $18.36
- NORTHERA (Drug) $18.31
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Edina
Rajiv Shah, M.d, M.D
Nephrology — Payments: $124,764
Jonathan Tolins, M.d, M.D
Nephrology — Payments: $24,929
George O'bryan, M.d, M.D
Nephrology — Payments: $854.16
David Bowlin, M.d, M.D
Nephrology — Payments: $811.30
Teija Madhusoodanan
Nephrology — Payments: $70.50
James Somerville, M.d, M.D
Nephrology — Payments: $12.47